Dr Cynthia A Purviance, MD - Medicare Emergency Medicine in La Jolla, CA

Dr Cynthia A Purviance, MD is a medicare enrolled "Emergency Medicine" physician in La Jolla, California. Her current practice location is 8910 Villa La Jolla Dr, La Jolla, California. You can reach out to her office (for appointments etc.) via phone at (858) 249-6800.

Dr Cynthia A Purviance is licensed to practice in California (license number A61273) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1851370555.

Contact Information

Dr Cynthia A Purviance, MD
8910 Villa La Jolla Dr,
La Jolla, CA 92037
(858) 249-6800
(858) 539-8781



Physician's Profile

Full NameDr Cynthia A Purviance
GenderFemale
SpecialityEmergency Medicine
Location8910 Villa La Jolla Dr, La Jolla, California
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1851370555
  • Provider Enumeration Date: 01/11/2006
  • Last Update Date: 10/04/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 2062301088
  • Enrollment ID: I20040317000805

Medical Identifiers

Medical identifiers for Dr Cynthia A Purviance such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1851370555NPI-NPPES
00A612730MedicaidCA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine A61273 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Cynthia A Purviance allows following entities to bill medicare on her behalf.
Entity NameRegents Of The University Of California
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780870899
PECOS PAC ID: 6406760131
Enrollment ID: O20031117000940

News Archive

New compound can enhance apoptosis in cancer cells

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis.

New report compares U.S. and European funding for research related to synthetic biology

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

St. Andrews Country Club of Boca Raton members teamed up with LPGA Tour player Morgan Pressel this week to raise $405,000 through the 3rd annual 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer through early detection and treatment.

Integrative Medicine helps people heal faster

The body has an innate desire to heal itself. Encouraging self-healing is the focus of Greenwich Hospital's Integrative Medicine Program.

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).

Read more Medical News

› Verified 5 days ago

Entity NameRegents Of The University Of California
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578672184
PECOS PAC ID: 3577476761
Enrollment ID: O20031211000464

News Archive

New compound can enhance apoptosis in cancer cells

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis.

New report compares U.S. and European funding for research related to synthetic biology

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

St. Andrews Country Club of Boca Raton members teamed up with LPGA Tour player Morgan Pressel this week to raise $405,000 through the 3rd annual 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer through early detection and treatment.

Integrative Medicine helps people heal faster

The body has an innate desire to heal itself. Encouraging self-healing is the focus of Greenwich Hospital's Integrative Medicine Program.

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).

Read more Medical News

› Verified 5 days ago

Entity NameAmerican Current Care Of California A Medical Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750573622
PECOS PAC ID: 5799854303
Enrollment ID: O20080522000420

News Archive

New compound can enhance apoptosis in cancer cells

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis.

New report compares U.S. and European funding for research related to synthetic biology

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

St. Andrews Country Club of Boca Raton members teamed up with LPGA Tour player Morgan Pressel this week to raise $405,000 through the 3rd annual 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer through early detection and treatment.

Integrative Medicine helps people heal faster

The body has an innate desire to heal itself. Encouraging self-healing is the focus of Greenwich Hospital's Integrative Medicine Program.

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).

Read more Medical News

› Verified 5 days ago

Entity NameApex Emergency Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1265711089
PECOS PAC ID: 4688844277
Enrollment ID: O20110909002790

News Archive

New compound can enhance apoptosis in cancer cells

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis.

New report compares U.S. and European funding for research related to synthetic biology

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

St. Andrews Country Club of Boca Raton members teamed up with LPGA Tour player Morgan Pressel this week to raise $405,000 through the 3rd annual 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer through early detection and treatment.

Integrative Medicine helps people heal faster

The body has an innate desire to heal itself. Encouraging self-healing is the focus of Greenwich Hospital's Integrative Medicine Program.

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).

Read more Medical News

› Verified 5 days ago

Entity NameUc San Diego Health Community Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659864247
PECOS PAC ID: 3971849175
Enrollment ID: O20190109000943

News Archive

New compound can enhance apoptosis in cancer cells

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis.

New report compares U.S. and European funding for research related to synthetic biology

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

St. Andrews Country Club of Boca Raton members teamed up with LPGA Tour player Morgan Pressel this week to raise $405,000 through the 3rd annual 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer through early detection and treatment.

Integrative Medicine helps people heal faster

The body has an innate desire to heal itself. Encouraging self-healing is the focus of Greenwich Hospital's Integrative Medicine Program.

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Cynthia A Purviance is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Cynthia A Purviance, MD
Po Box 232410,
San Diego, CA 92193-2410

Ph: () -
Dr Cynthia A Purviance, MD
8910 Villa La Jolla Dr,
La Jolla, CA 92037

Ph: (858) 249-6800

News Archive

New compound can enhance apoptosis in cancer cells

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis.

New report compares U.S. and European funding for research related to synthetic biology

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

St. Andrews Country Club of Boca Raton members teamed up with LPGA Tour player Morgan Pressel this week to raise $405,000 through the 3rd annual 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer through early detection and treatment.

Integrative Medicine helps people heal faster

The body has an innate desire to heal itself. Encouraging self-healing is the focus of Greenwich Hospital's Integrative Medicine Program.

Phase 1b clinical trial of JX-594 in metastatic, refractory colorectal cancer commences in Korea

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).

Read more News

› Verified 5 days ago


Emergency Medicine Doctors in La Jolla, CA

Mrs. Susan Elizabeth Mckim, PA-C
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037
Phone: 858-554-8646    Fax: 858-554-6271
Dr. Monte Tim Mellon, M.D. M.B.A.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 9888 Genesee Ave, La Jolla, CA 92037
Phone: 858-626-6150    Fax: 858-626-7117
Richard M Obler, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 354 Ricardo Pl, La Jolla, CA 92037
Phone: 858-922-1073    
Ian R Grover, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 9300 Campus Point Drive, La Jolla, CA 92037
Phone: 858-657-7000    
Ian Reilly, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 9888 Genesee Ave, La Jolla, CA 92037
Phone: 858-354-6049    
George R Baehr, M.D.
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 10710 N Torrey Pines Rd, La Jolla, CA 92037
Phone: 858-554-8638    
Sean X Neath, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037
Phone: 858-657-7000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.